Metabolic and Neuromuscular Unit, Meyer Children Hospital, University of Florence, Florence, Italy.
Mol Genet Genomic Med. 2023 Jan;11(1):e2073. doi: 10.1002/mgg3.2073. Epub 2022 Nov 4.
Methylmalonic acidemia (MMA) is an inborn error of metabolism whose optimal management, especially in the long-term remains to be established.
We describe the case of a child with MMA mut who was in a cycle of episodes of decompensation and hospitalization when we started to use carglumic acid (CA), a well-known adjunctive therapy to standard care for the treatment of acute hyperammonemia due to MMA.
Using the lowest effective therapeutic dose of CA and adjusting the patient's diet with caloric and protein intake adequate for her age and pathology, we managed to keep ammonium levels within the normal range, and to ensure a normal growth pattern.
The present case adds further confirmation of the long-term management of MMA using CA, focusing on the long duration of follow up and on the use of a lower dose of CA in real life settings.
甲基丙二酸血症(MMA)是一种先天性代谢错误,其最佳管理方法,特别是长期管理方法仍有待建立。
我们描述了一例 MMA mut 患儿的病例,当我们开始使用瓜氨酸(CA)时,该患儿处于失代偿和住院的循环中,CA 是一种辅助治疗 MMA 引起的急性高氨血症的标准治疗方法。
使用最低有效治疗剂量的 CA,并根据患者的年龄和病理情况调整热量和蛋白质摄入,使我们能够将铵水平保持在正常范围内,并确保正常的生长模式。
本病例进一步证实了 CA 在 MMA 长期管理中的应用,重点是长期随访和在实际环境中使用较低剂量的 CA。